Free Trial

Abbott Laboratories (ABT) SEC Filings & 10K Form

Abbott Laboratories logo
$131.94 -1.66 (-1.24%)
Closing price 07/11/2025 03:58 PM Eastern
Extended Trading
$132.00 +0.06 (+0.05%)
As of 07/11/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Abbott Laboratories SEC Filings

DateFilerForm TypeView
07/01/2025
4:32 PM
Abbott Laboratories (Issuer)
Stratton John G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025
4:13 PM
Abbott Laboratories (Issuer)
Gonzalez Patricia Paola (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025
4:24 PM
Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025
3:40 PM
Abbott Laboratories (Issuer)
Cushman Elizabeth C. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/01/2025
3:47 PM
Abbott Laboratories (Issuer)
Cushman Elizabeth C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2025
10:01 AM
Abbott Laboratories (Filer)
Form SD
Specialized Disclosure Report  
04/29/2025
5:30 PM
Abbott Laboratories (Issuer)
Stratton John G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2025
4:49 PM
Abbott Laboratories (Issuer)
McDew Darren W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2025
4:58 PM
Abbott Laboratories (Issuer)
McKinstry Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2025
5:06 PM
Abbott Laboratories (Issuer)
O'Grady Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2025
5:14 PM
Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2025
5:22 PM
Abbott Laboratories (Issuer)
STARKS DANIEL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2025
4:19 PM
Abbott Laboratories (Issuer)
Blount Sally E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2025
4:30 PM
Abbott Laboratories (Issuer)
Gonzalez Patricia Paola (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2025
4:40 PM
Abbott Laboratories (Issuer)
Kumbier Michelle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2025
3:10 PM
Abbott Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2025
6:36 AM
Abbott Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2025
4:39 PM
Abbott Laboratories (Issuer)
Stratton John G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
4:30 PM
Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
4:05 PM
Abbott Laboratories (Issuer)
Alpern Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
5:55 PM
Abbott Laboratories (Issuer)
Earnhardt Lisa D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
5:28 PM
Abbott Laboratories (Subject)
Earnhardt Lisa D (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2025
4:47 PM
Abbott Laboratories (Subject)
Earnhardt Lisa D (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
6:54 PM
Abbott Laboratories (Issuer)
Salvadori Daniel Gesua Sive (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:00 PM
Abbott Laboratories (Issuer)
Shroff Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:05 PM
Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:33 PM
Abbott Laboratories (Issuer)
Ford Robert B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:39 PM
Abbott Laboratories (Issuer)
MCCOY JOHN A. JR. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:44 PM
Abbott Laboratories (Issuer)
Moreland Mary K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:21 PM
Abbott Laboratories (Issuer)
Boudreau Philip P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:27 PM
Abbott Laboratories (Issuer)
Earnhardt Lisa D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:00 PM
Abbott Laboratories (Issuer)
ALLEN HUBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
7:40 PM
Abbott Laboratories (Subject)
Shroff Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
7:29 PM
Abbott Laboratories (Issuer)
Shroff Eric (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/03/2025
6:58 PM
Abbott Laboratories (Subject)
Moreland Mary K (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
7:08 PM
Abbott Laboratories (Subject)
Morrone Louis H. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
7:18 PM
Abbott Laboratories (Subject)
Wainer Andrea F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
6:52 PM
Abbott Laboratories (Subject)
MCCOY JOHN A. JR. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2025
5:47 PM
Abbott Laboratories (Issuer)
Salvadori Daniel Gesua Sive (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
5:56 PM
Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
5:07 PM
Abbott Laboratories (Issuer)
Ford Robert B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Gold is soaring. Here’s how to get paid from it (Ad)

Gold just broke through $3,300… And while the headlines shout about price targets, something even more powerful is happening behind the scenes… Some investors are using a little-known ETF to collect up to $1,152/month from gold's surge. No trading gold futures. No mining stocks. No vaults. Just a simple fund delivering monthly payouts — like clockwork.

Click here to discover the income ETF behind it all.
02/27/2025
5:17 PM
Abbott Laboratories (Issuer)
MCCOY JOHN A. JR. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
5:26 PM
Abbott Laboratories (Issuer)
Moreland Mary K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
5:35 PM
Abbott Laboratories (Issuer)
Morrone Louis H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
4:37 PM
Abbott Laboratories (Issuer)
ALLEN HUBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
4:46 PM
Abbott Laboratories (Issuer)
Boudreau Philip P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
4:51 PM
Abbott Laboratories (Issuer)
Ford Robert B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
5:52 PM
Abbott Laboratories (Subject)
Ford Robert B (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
6:08 PM
Abbott Laboratories (Issuer)
Salvadori Daniel Gesua Sive (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
6:16 PM
Abbott Laboratories (Issuer)
ALLEN HUBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
6:33 PM
Abbott Laboratories (Issuer)
Morrone Louis H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
4:33 PM
Abbott Laboratories (Subject)
ALLEN HUBERT L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/30/2025
4:26 PM
Abbott Laboratories (Subject)
Salvadori Daniel Gesua Sive (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2025
4:30 PM
Abbott Laboratories (Subject)
ALLEN HUBERT L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2025
6:13 AM
Abbott Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2025
4:26 PM
Abbott Laboratories (Issuer)
Stratton John G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2024
4:14 PM
Abbott Laboratories (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/23/2024
4:10 PM
Abbott Laboratories (Issuer)
ALLEN HUBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2024
6:37 AM
Abbott Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2024
4:27 PM
Abbott Laboratories (Issuer)
Alpern Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
4:33 PM
Abbott Laboratories (Issuer)
Gonzalez Patricia Paola (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
4:39 PM
Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
4:48 PM
Abbott Laboratories (Issuer)
Stratton John G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
4:24 PM
Abbott Laboratories (Issuer)
Ford Robert B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
5:20 PM
Abbott Laboratories (Subject)
Ford Robert B (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2024
7:03 PM
Abbott Laboratories (Issuer)
Boudreau Philip P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
6:52 PM
Abbott Laboratories (Issuer)
MCCOY JOHN A. JR. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
3:02 PM
Abbott Laboratories (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/18/2024
6:37 AM
Abbott Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:ABT) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners